179 related articles for article (PubMed ID: 24045669)
21. A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II).
Nishikawa K; Tsuburaya A; Yoshikawa T; Kobayashi M; Kawada J; Fukushima R; Matsui T; Tanabe K; Yamaguchi K; Yoshino S; Takahashi M; Hirabayashi N; Sato S; Nemoto H; Rino Y; Nakajima J; Aoyama T; Miyagi Y; Oriuchi N; Yamaguchi K; Miyashita Y; Morita S; Sakamoto J
Eur J Cancer; 2018 Sep; 101():220-228. PubMed ID: 30096702
[TBL] [Abstract][Full Text] [Related]
22. Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer.
Shukuya T; Takahashi T; Harada H; Akamatsu H; Sakaguchi C; Imai H; Ono A; Nakamura Y; Tsuya A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi K; Yamamoto N
Anticancer Res; 2012 Feb; 32(2):675-80. PubMed ID: 22287762
[TBL] [Abstract][Full Text] [Related]
23. [TS-1/CDDP therapy for advanced gastric cancer as neoadjuvant chemotherapy].
Nakamura M; Maruyama K; Furukawa J; Maruyama N; Tanaka J; Katsumoto Y; Yokouchi H; Nakaguchi K; Sue F; Yoshihara W
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1823-8. PubMed ID: 12402437
[TBL] [Abstract][Full Text] [Related]
24. Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer.
Satoh T; Yamada Y; Muro K; Hayashi H; Shimada Y; Takahari D; Taku K; Nakajima TE; Shi X; Brown KH; Boku N
Cancer Chemother Pharmacol; 2012 Feb; 69(2):439-46. PubMed ID: 21853311
[TBL] [Abstract][Full Text] [Related]
25. A phase II multicentric trial of S-1 combined with 24 h-infusion of cisplatin in patients with advanced gastric cancer.
Iwase H; Shimada M; Tsuzuki T; Horiuchi Y; Kumada S; Haruta J; Yamaguchi T; Sugihara M; Ina K; Kusugami K; Goto S
Anticancer Res; 2005; 25(2B):1297-301. PubMed ID: 15865081
[TBL] [Abstract][Full Text] [Related]
26. Feasibility and efficacy of combination chemotherapy with S-1 and fractional Cisplatin for advanced gastric cancer.
Takahashi T; Saikawa Y; Takaishi H; Takeuchi H; Wada N; Oyama T; Nakamura R; Kitagawa Y
Anticancer Res; 2010 Sep; 30(9):3759-62. PubMed ID: 20944165
[TBL] [Abstract][Full Text] [Related]
27. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
Nakata B; Hirakawa K
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921
[TBL] [Abstract][Full Text] [Related]
28. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
Boku N; Yamamoto S; Fukuda H; Shirao K; Doi T; Sawaki A; Koizumi W; Saito H; Yamaguchi K; Takiuchi H; Nasu J; Ohtsu A;
Lancet Oncol; 2009 Nov; 10(11):1063-9. PubMed ID: 19818685
[TBL] [Abstract][Full Text] [Related]
29. Irinotecan plus cisplatin therapy and S-1 plus cisplatin therapy for advanced or recurrent gastric cancer in a single institution.
Nakashima K; Hironaka S; Boku N; Onozawa Y; Fukutomi A; Yamazaki K; Yasui H; Taku K; Kojima T; Machida N
Jpn J Clin Oncol; 2008 Dec; 38(12):810-5. PubMed ID: 18988666
[TBL] [Abstract][Full Text] [Related]
30. Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial.
Kim SB; Yoo C; Ro J; Im SA; Im YH; Kim JH; Ahn JH; Jung KH; Song HS; Kang SY; Park HS; Chung HC
Invest New Drugs; 2014 Aug; 32(4):753-61. PubMed ID: 24715580
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
[TBL] [Abstract][Full Text] [Related]
32. [Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer].
Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Azuma M; Shimoda T; Nishimura K; Nakatani K; Saigenji K
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1957-61. PubMed ID: 15570920
[TBL] [Abstract][Full Text] [Related]
33. [Combination chemotherapy of S-1/low-dose CDDP/lentinan for advanced gastric cancer].
Hori T; Ikehara T; Takatsuka S; Fukuoka T; Tendo M; Tezuka K; Dan N; Nishino H; Hirakawa K
Gan To Kagaku Ryoho; 2011 Feb; 38(2):293-5. PubMed ID: 21368498
[TBL] [Abstract][Full Text] [Related]
34. Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin.
Nishina T; Azuma M; Nishikawa K; Gotoh M; Bando H; Sugimoto N; Amagai K; Chin K; Niwa Y; Tsuji A; Imamura H; Tsuda M; Yasui H; Fujii H; Yamaguchi K; Yasui H; Hironaka S; Shimada K; Miwa H; Mitome T; Kageyama H; Hyodo I
Gastric Cancer; 2019 Jan; 22(1):138-146. PubMed ID: 29948386
[TBL] [Abstract][Full Text] [Related]
35. [Cisplatin and S-1 combination therapy after reduction surgery for stage IV gastric cancer].
Taniwaki S; Saruwatari A; Yoshida T; Mizoguchi A; Kitasato Y; Kitamura T; Hidaka A; Shiota K; Kuroda H; Tanaka M; Higashi T; Iwanaga Y; Ogata Y
Gan To Kagaku Ryoho; 2009 Feb; 36(2):279-82. PubMed ID: 19223745
[TBL] [Abstract][Full Text] [Related]
36. Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial.
Nishikawa K; Fujitani K; Inagaki H; Akamaru Y; Tokunaga S; Takagi M; Tamura S; Sugimoto N; Shigematsu T; Yoshikawa T; Ishiguro T; Nakamura M; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J; Tsujinaka T
Eur J Cancer; 2015 May; 51(7):808-16. PubMed ID: 25797356
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer.
Sakaguchi Y; Kabashima A; Okita K; Ojima Y; Yamamura S; Nishizaki T; Tashiro H; Matsusaka T
Gastric Cancer; 2005; 8(2):111-6. PubMed ID: 15864718
[TBL] [Abstract][Full Text] [Related]
38. Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer.
Choi IS; Lee KW; Kim KH; Kim YJ; Kim JH; Lee JS
Med Oncol; 2010 Sep; 27(3):992-7. PubMed ID: 20077040
[TBL] [Abstract][Full Text] [Related]
39. [The feasibility of CDDP administration for gastric cancer outpatients undergoing S-1/cisplatin combination therapy].
Kishimoto T; Imamura H; Kawabata R; Kimura Y; Fujii C; Fukunaga M; Ohzato H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2304-6. PubMed ID: 23268058
[TBL] [Abstract][Full Text] [Related]
40. Relationship between expression of vascular endothelial growth factor in tumor tissue from gastric cancers and chemotherapy effects: comparison between S-1 alone and the combination of S-1 plus CDDP.
Boku N; Ohtsu A; Nagashima F; Shirao K; Koizumi W
Jpn J Clin Oncol; 2007 Jul; 37(7):509-14. PubMed ID: 17673469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
